발열 5일 이전과 이후에 방문한 가와사키병 환자의 급성기반응물질 결과 비교
Comparison of acute phase reactant levels of Kawasaki disease patients who visited with less than 5 days duration of fever and with 5 days or longer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Kawasaki disease (KD) is a common, acute systemic vasculitis in children. Acute phase reactants (APRs) have been used to assist diagnosis, and to predict outcome in children with KD. However, it remains unknown on levels of APRs depending on duration of fever. We aimed to compare APR levels of children with KD who visited with < 5 days duration of fever and with ≥ 5 days. Methods: Children (≤ 15 years) with complete KD who visited the emergency department were enrolled from March 2012 through February 2018. The children were divided into the early (fever < 5 days) and late (fever ≥ 5 days) presenters. The baseline characteristics, APR levels, such as platelet count, and outcomes were compared between the 2 groups. Results: A total of 145 children with complete KD were enrolled. Median age was 27.0 (interquartile range [IQR], 12.0-46.5) months, and boys accounted for 60.0%. The early presenters (63 [43.4%]) had a younger age (17.0 [IQR, 7.0-45.0] vs. 32.5 [IQR, 14.0-48.0] months; P = 0.006), shorter duration of fever (3.0 [IQR, 2.0-4.0] vs. 6.0 [IQR, 5.0-7.0] days; P < 0.001), and a lower platelet count (336.7 ± 105.2 [× 103/μL] vs. 381.6 ± 121.8 [× 103/μL], P = 0.02) than the late presenters. The other APR levels, and frequency of resistance to intravenous immunoglobulin and coronary artery abnormalities showed no differences between the 2 groups. Conclusion: Children with KD who visited with < 5 days duration of fever had a lower platelet count compared to those with ≥ 5 days. No differences were found in the other APR levels and the outcomes. It may be necessary to consider the differences in APR levels depending on duration of fever when treating children with KD.
Abstract
Purpose: Kawasaki disease (KD) is a common, acute systemic vasculitis in children. Acute phase reactants (APRs) have been used to assist diagnosis, and to predict outcome in children with KD. However, it remains unknown on levels of APRs depending on duration of fever. We aimed to compare APR levels of children with KD who visited with < 5 days duration of fever and with ≥ 5 days. Methods: Children (≤ 15 years) with complete KD who visited the emergency department were enrolled from March 2012 through February 2018. The children were divided into the early (fever < 5 days) and late (fever ≥ 5 days) presenters. The baseline characteristics, APR levels, such as platelet count, and outcomes were compared between the 2 groups. Results: A total of 145 children with complete KD were enrolled. Median age was 27.0 (interquartile range [IQR], 12.0-46.5) months, and boys accounted for 60.0%. The early presenters (63 [43.4%]) had a younger age (17.0 [IQR, 7.0-45.0] vs. 32.5 [IQR, 14.0-48.0] months; P = 0.006), shorter duration of fever (3.0 [IQR, 2.0-4.0] vs. 6.0 [IQR, 5.0-7.0] days; P < 0.001), and a lower platelet count (336.7 ± 105.2 [× 103/μL] vs. 381.6 ± 121.8 [× 103/μL], P = 0.02) than the late presenters. The other APR levels, and frequency of resistance to intravenous immunoglobulin and coronary artery abnormalities showed no differences between the 2 groups. Conclusion: Children with KD who visited with < 5 days duration of fever had a lower platelet count compared to those with ≥ 5 days. No differences were found in the other APR levels and the outcomes. It may be necessary to consider the differences in APR levels depending on duration of fever when treating children with KD.
참고문헌 (20)
- McCrindle BW, "Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association", Circulation, 135, pp.e927~e999 (2017)
- Oates-Whitehead RM, "Intravenous immunoglobulin for the treatment of Kawasaki disease in children", Cochrane Database Syst Rev, 4, pp.CD004000~ (2003)
- Mori M, "Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease", Mod Rheumatol, 14, pp.361~366 (2004)
- Pilania RK, "Controversies in diagnosis and management of Kawasaki disease", World J Clin Pediatr, 7, pp.27~35 (2018)
- Huang MY, "Acute-phase reactants and a supplemental diagnostic aid for Kawasaki disease", Pediatr Cardiol, 31, pp.1209~1213 (2010)
- Jo S, "Pro-brain natriuretic peptide as predictive factor for cardiovascular abnormalities in children with incomplete Kawasaki disease in emergency department", Pediatr Emerg Med J, 2, pp.75~80 (2015)
- Xie T, "Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease", Pediatr Rheumatol Online J, 15, pp.17~ (2017)
- Xiu-Yu S, "Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis", J Clin Lab Anal, 24, pp.385~388 (2010)
- Dionne A, "N-terminal pro-B-type natriuretic peptide diagnostic algorithm versus American Heart Association algorithm for Kawasaki disease", Pediatr Int, 59, pp.265~270 (2017)
- 하기수, "Laboratory Markers in Incomplete Kawasaki Disease according to Coronary Artery Outcome", Korean Circulation Journal, 48(4), pp.287~295 (2018), 대한심장학회[DOI]
- 이윤숙, "C-reactive Protein and Erythrocyte Sedimentation Rate Discrepancies and Variations after Intravenous Immunoglobulin Therapy in Kawasaki Disease", Pediatric Infection and Vaccine, 23(1), pp.25~30 (2016), 대한소아감염학회
- Tremoulet AH, "Evolution of laboratory values in patients with Kawasaki disease", Pediatr Infect Dis J, 30, pp.1022~1026 (2011)
- Kwon H., "N-terminal pro-brain natriuretic peptide, adjuvant laboratory marker of acute phase of Kawasaki disease in emergency department", Pediatr Emerg Med J, 1, pp.96~101 (2014)
- Shiari R., "Kawasaki disease: a review article", Arch Pediatr Infect Dis, 2, pp.154~159 (2014)
- Stemberger Maric L, "Challenges in early diagnosis of Kawasaki disease in the pediatric emergency department: differentiation from adenoviral and invasive pneumococcal disease", Wien Klin Wochenschr, 130, pp.264~272 (2018)
- Ruan Y, "Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China", Pediatr Infect Dis J, 32, pp.e397~e402 (2013)
- Sang Min Lee, "Prediction of Resistance to Standard Intravenous Immunoglobulin Therapy in Kawasaki Disease", Korean Circulation Journal, 44(6), pp.415~422 (2014), 대한심장학회
- 신재은, "Verification of Current Risk Scores for Kawasaki Disease in Korean Children", Journal of Korean Medical Science, 32(12), pp.1991~1996 (2017), 대한의학회
- Takeuchi M, "Novel risk assessment tool for immunoglobulin resistance in Kawasaki disease: application using a random forest classifier", Pediatr Infect Dis J, 36, pp.821~826 (2017)
- Mori M, "Predictors of coronary artery lesions after intravenous gammaglobulin treatment in Kawasaki disease", J Pediatr, 137, pp.177~180 (2000)